|
Guangzhou Baiyunshan Phar Hldgs Co Ltd is a pharmaceutical and healthcare group engaged in the research, development, manufacturing, and sales of pharmaceutical products. The company operates across several business segments, including modern traditional Chinese medicine, chemical pharmaceuticals, natural beverages, pharmaceutical commerce, biological innovation, consumer health, and medical services. Its activities cover the wholesale, retail, and import/export of western medicines, traditional Chinese medicines, and medical devices, as well as the provision of hospital medical services and health preservation. The group serves domestic and international markets through its diversified product portfolio and distribution network. It was established in 1997 following the restructuring of eight traditional Chinese medicine manufacturing enterprises and three pharmaceutical trading enterprises under its controlling shareholder, Guangzhou Pharmaceutical Group Co., Ltd. Summarised from the company's own disclosures, fiscal year ended Apr 2026 |
Industry Drug Manufacturers - General | Homepage gybys.com.cn |
| Sector Healthcare | IR page gybys.com.cn/investment/Investor.html | |
|
Tags
traditional chinese medicine, chemical pharmaceuticals, biological products, healthcare services, pharmaceutical distribution, consumer health, medical devices, natural beverages, Guangyao Baiyunshan Hong Kong Company, Guangzhou Hua Cheng Pharmaceutical Factory, Guangdong Yili Pharmaceutical Co. Ltd.
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 2.72B |
| Market cap (USD) | $ 346.641M |
| P/E | 6.02 |
| PEG | — |
| P/BV | — |
| P/S | — |
| P/OCF | — |
| P/FCF | — |
| Dividend yield | 7.0% |
| Turnover / mcap | 0.49% |
| Returns | |
|---|---|
| ROE | 7.7% |
| ROI | 5.6% |
| ROIC | 5.7% |
| Profit margin | 3.8% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -9.1% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | — |
| Diluting (TTM) | — |
| Debt/Equity | 42.6% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 23.1% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 77.656B | 74.993B | 75.515B | 70.788B | 69.014B | 61.674B | 64.952B | 42.234B | 20.954B | — | — | — | — | — | — | 4.403B |
| Net profit | 2.983B | 2.835B | 4.056B | 3.967B | — | 3.092B | 3.189B | 3.441B | 2.119B | — | — | — | — | — | — | 279.597M |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Guangzhou Baiyunshan Phar Hldgs Co Ltd
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.






































